Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

24.34
+0.23000.95%
Pre-market: 24.890.5500+2.26%07:29 EDT
Volume:563.47K
Turnover:13.67M
Market Cap:1.15B
PE:8.80
High:24.57
Open:24.05
Low:23.60
Close:24.11
Loading ...

Amphastar Pharmaceuticals Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
Yesterday

JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45

MT Newswires Live
·
Yesterday

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources

Reuters
·
Yesterday

Amphastar Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Amphastar Pharmaceuticals Is Maintained at Overweight by Wells Fargo

Dow Jones
·
08 May

Amphastar Pharmaceuticals, Inc. : Wells Fargo Cuts Target Price to $35 From $40

THOMSON REUTERS
·
08 May

Amphastar Pharma Q1 Adj. EPS $0.74 Beats $0.69 Estimate, Sales $170.53M Miss $172.94M Estimate

Benzinga
·
08 May

Amphastar Pharmaceuticals Q1 Net Income USD 25.285 Million

THOMSON REUTERS
·
08 May

Director Floyd F. Petersen Reports Disposal of Common Shares in Amphastar Pharmaceuticals Inc

Reuters
·
03 May

Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?

Zacks
·
02 May

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

ACCESS Newswire
·
30 Apr

2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice About

StockStory
·
24 Apr

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36

MT Newswires Live
·
21 Apr

Amphastar Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $31 From $36

THOMSON REUTERS
·
21 Apr

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey
·
16 Apr

2 Reasons to Like AMPH and 1 to Stay Skeptical

StockStory
·
15 Apr

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESS Newswire
·
28 Mar

Amphastar Pharmaceuticals Is Maintained at Neutral by Piper Sandler

Dow Jones
·
21 Mar

On Nasdaq, I Prefer the Less-Famous Stocks

GuruFocus.com
·
18 Mar

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory
·
13 Mar